← Leaderboards
Jihoon Lee
University Of Texas Hlth Science Center
$1,127,164
Attributed
$1,127,164
Total exposure
1
Grants
1
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $385.5K · FY2023–25$500K$375K$250K$125K$0
'23
'24
'25
Funding mix
By agency
NIH$1,127,164 · 1
By mechanism
R01$1,127,164 · 1
Top collaborators
No co-investigators on record.
Most similar at University Of Texas Hlth Science Center
Same institution · by research overlap
- David A Morilak$17,637,191
- David Gius$12,824,808
- Sandeep Burma$8,062,293
- Peter J Houghton$32,798,876
- Ganesh V Raj$2,616,233
Others in their field
Other Rising Stars on “Enhancers”
- Angee Greer · Ppd Development Lp$82,531,927
- Jeffrey Leintz · National Opinion Research Center$39,962,545
- Cyrus Wadia · Activate Global, Inc.$31,489,493
- Bridget Murphy · Broad Institute, Inc.$23,600,775
- Rashada Alexander · American Association For The Advancement Of Science$22,676,040
- Rebecca Montalvan · Westat, Inc.$20,000,000
Research focus
EnhancersAbirateroneAdenosineAndrogen Deprivation TherapyAdvanced Prostate CancerAndrogen ReceptorAffectAntagonistBindingBiological ProcessCancer DiagnosisCancer PatientCancer SurvivalCastrationAndrogensCessation Of LifeChip-SeqChromatinComplexDepositionDrug RelapseDrug ResistanceDrug Resistance DevelopmentEnzalutamide
Grant awards (3)
The role and mechanism of RNA m6A modification in the pathogenesis and drug-resistance of prostate cancer$375,411
R01 · FY2025 · CA · contact PI
The role and mechanism of RNA m6A modification in the pathogenesis and drug-resistance of prostate cancer$366,240
R01 · FY2024 · CA · contact PI
The role and mechanism of RNA m6A modification in the pathogenesis and drug-resistance of prostate cancer$385,513
R01 · FY2023 · CA · contact PI